Cowen Downgrades Regulus Therapeutics (RGLS) to Market Perform

November 2, 2016 7:10 AM EDT
Get Alerts RGLS Hot Sheet
Price: $2.45 --0%

Rating Summary:
    7 Buy, 2 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 10 | New: 3
Trade RGLS Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Cowen downgraded Regulus Therapeutics (NASDAQ: RGLS) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Regulus Therapeutics click here. For more ratings news on Regulus Therapeutics click here.

Shares of Regulus Therapeutics closed at $2.80 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Cowen & Co

Add Your Comment